A second chance for new antibiotic agent

More and more bacteria are developing resistance to antibiotics. Researchers are therefore looking for alternative active ingredients.
Credit: © RUB, Marquard

Significant attempts 20 years ago…

The study focused on the protein peptide deformylase (PDF). Involved in protein maturation processes in cells, PDF is essential for the survival of bacteria. However, it’s found in both bacteria and human cells. “Some 20 years ago, significant attempts were made to combat PDF with antibiotic agents,” Raphael Stoll points out.

“Yet, the original drug candidate, i.e. actinonin, had to be discarded for several reasons. One of the problems faced was the newly discovered human PDF, which was potentially associated with side effects. Still, further research was carried out to generate modified active compounds,” Hendrik Kirschner adds.

As part of his doctoral thesis, he examined PDF in detail in the current study and analysed it from the perspective of structural biology using biomolecular nuclear magnetic resonance (NMR) spectroscopy and X-ray crystallography. These techniques enabled him to obtain a 3D structure resolved at the smallest detail. “This is the result of many years of collaborating with our colleague Professor Eckhard Hofmann,” Raphael Stoll says.

Active molecule is adapted and made more selective

“We can use these techniques to visualize surfaces and binding pockets of biomolecules and show that the binding of molecule to this protein is not static, but dynamic,” Hendrik Kirschner explains. The researchers noticed that there are two different binding orientations in the protein for a modified drug molecule: In addition to the orientation that is also present in human PDF, there’s another one that should, in principle, exclusively occur in bacterial PDF.

“This prompts us to modify the drug molecule so that it favours the second binding orientation,” Raphael Stoll says. As a result, the antibiotic molecule could be rendered more selective. “It could provide this drug candidate with a second chance,” Hendrik Kirschner concludes.

Journal: Journal of Medicinal Chemistry
DOI: 10.1021/acs.jmedchem.3c02382
Method of Research: Experimental study
Subject of Research: Cells
Article Title: Toward More Selective Antibiotic Inhibitors: A Structural View of the Complexed Binding Pocket of E. coli Peptide Deformylase
Article Publication Date: 4-Apr-2024

Media Contact

Meike Driessen
Ruhr-University Bochum
Office: 49-234-32-26952

Expert Contact

Dr. Hendrik Kirschner
Biomolecular NMR Spectroscopy, Faculty of Chemistry and Biochemistry, Ruhr University of Bochum, Germany
Office: +49 234 32 26246

Media Contact

Meike Driessen
Ruhr-University Bochum

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

‘Invisible’ protein keeps cancer at bay

Scientists in Germany have revealed how an unstructured protein traps cancer-promoting molecules. Each second of our lives, cells in our body grow and divide to ensure we stay healthy. However,…

Practical 3D tracking at record-breaking speeds

With speeds over 200 times faster than traditional methods, new technology could benefit autonomous driving, industrial inspection and security applications. Researchers have developed a new 3D method that can be…

Scientists discover new behavior of membranes

…that could lead to unprecedented separations. Researchers use new technique to overcome perceived limitation of membranes with pores of consistent size. Imagine a close basketball game that comes down to…

Partners & Sponsors